| AXIM
Cefuroxime

Description:
Axim is
a preparation of Cefuroxime. Cefuroxime is a semi-synthetic,
broad-spectrum 2nd generation cephalosporin antibiotic
for oral & parenteral administration.
Composition:
Axim Tablet
125 mg: Each film coated tablet contains Cefuroxime Axetil
USP equivalent to Cefuroxime 125 mg.
Axim Tablet
250 mg: Each film coated tablet contains Cefuroxime Axetil
USP equivalent to Cefuroxime 250 mg.
Axim Tablet
500 mg: Each film coated tablet contains Cefuroxime Axetil
USP equivalent to Cefuroxime 500 mg.
Axim powder
for suspension: After reconstitution each 5 ml contains
Cefuroxime Axetil USP equivalent to Cefuroxime 125 mg.
Axim Injection
750 mg: Each vial contains Cefuroxime Sodium USP sterile
powder equivalent to Cefuroxime 750 mg.
Clinical Pharmacology:
Axim is
active against a wide range of gram-positive & gram-negative
bacteria including Staphylococcus aureus, Streptococcus pyogenes,
Streptococcus pneumoniae, Neisseria spp, Haemophilus
influenzae and many common gram- negative hospital pathogenes
such as Escherichia coli, Klebsiella spp., Proteus
mirabilis. Axim has noteworthy activity against beta-lactamase
producing strains of Haemophilus influenzae and Neisseria
gonorrhoeae, which are resistant to ampicillin and penicillin.
Indications:
1. Upper and lower
respiratory tract infections, such as acute and chronic bronchitis,
pneumonia, sinusitis, otitis media, tonsillitis & pharyngitis.
2. Skin & soft tissue structure infections such as peritonitis,
wound infections and impetigo, 3. Urinary tract infections such
as pyelonephritis and cystitis. 4. Gonorrhoea. 5. Septicaemia.
6. Meningitis. 7. Prophylaxis against infections in abdominal,
pelvic, orthopedic, cardiac, pulmonary, oesophageal, & vascular
surgery. 8. Early Lyme disease.
Dosage &
Administration:
Oral:
Adolescents
and adults:
| Infections |
Dosage |
Duration (days) |
| Pharyngitis/tonsillitis |
250 mg b.i.d. |
10 |
| Acute bacterial maxillary
sinusitis |
250 mg b.i.d.
|
10 |
| Acute bacterial exacerbation
of chronic bronchitis |
250-500 mg b.i.d. |
10 |
| Secondary bacterial
infections of acute bronchitis |
250-500 mg b.i.d. |
5-10 |
| Uncomplicated skin and
skin structure infections |
250-500 mg b.i.d.
|
10 |
| Uncomplicated urinary
tract infections |
125 or 250 mg b.i.d.
|
7-10 |
| Gonorrhoea |
1000 mg once daily
|
Single dose |
| Early Lyme disease |
500 mg b.i.d.
|
20 |
Children over
3 months: 125 mg twice daily, if necessary doubled in children
over 2 years with acute otitis media.
Parenteral:
Adults:
Usual dose is 750 mg every three to four daily intravenously
or intramuscularly. In severe infections: 1.5 g IV 3-4 times
daily. Pneumonia: Sequential therapy: 1.5 g twice daily IV/IM
for 48/72 hours followed by 500 mg Cefuroxime oral therapy for
7 days. Acute exacerbation of chronic bronchitis: Sequential
therapy: 750 mg twice daily IV/IM for 48/72 hours followed by
500 mg Cefuroxime oral therapy for 5-10 days. Children above
3 months: 30-100 mg/kg body weight daily in equally divided
doses every 6 to 8 hours. Prophylaxis: 1.5 g IV/IM with
induction of anesthesia followed by 750 mg IM at 8 hours &
16 hours or three times daily for a further 24-48 hours.
Contraindications:
Patients with known
allergy to cephalosporins.
Adverse Reactions:
Diarrhoea and rarely
antibiotic-associated colitis (CSM has warned both more likely
with higher doses), nausea and vomiting, abdominal discomfort,
headache; allergic reactions including rashes, pruritus, urticaria,
serum sickness-like reactions with rashes, fever and arthralgia,
and anaphylaxis; erythema multiforme, toxic epidermal necrolysis
reported; disturbances in liver enzymes, transient hepatitis
and cholestatic jaundice; other side-effects reported include
eosinophilia and blood disorders (including thrombocytopenia,
leucopenia, agranulocytosis, aplastic anaemia and haemolytic
anaemia); reversible interstitial nephritis, hyperactivity,
nervousness, sleep disturbances, confusion, hypertonia, and
dizziness.
High Risk Group:
Children: Cefuroxime
Axetil cannot be used in children under 3 months of age.
Pregnant women:
While all antibiotics should be avoided in the first trimester
if possible cefuroxime has been safely used in later pregnancy
to treat urinary and other infections.
Drug Interaction:
No potentially
hazardous interaction has been reported.
Packing:
Axim Tablet
125 mg: Box containing 1x10's/2x10's tablets in alu/alu
blister pack.
Axim Tablet
250 mg: Box containing 1x10's tablets in alu/alu blister
pack.
Axim Tablet 500 mg: Box containing 1×10's tablets in alu-alu blister pack.
Axim powder
for suspension: Bottle containing dry powder for the reconstitution
of 70 ml suspension.
Axim IM
Injection 750 mg: Combipack of 1 vial of 750 mg Cefuroxime
(as sterile Cefuroxime Sodium USP) & 1 ampoule of 5 ml Water
for Injection BP.
|